Case Report {#sec1_1}
===========

This 34-year-old man had progressive visual loss in the left eye of 2 months. He was diagnosed with left optic neuritis, and systemic corticosteroids were prescribed. Magnetic resonance imaging of the brain was normal. Automated visual fields were symmetrically normal. After seeking a second opinion 14 days later, best-corrected visual acuity (BCVA) of the left eye was 20/100 (6/30) with diffuse disc elevation and peripapillary nerve fiber hemorrhage (fig. [1a](#F1){ref-type="fig"}). There was absence of anterior chamber or vitreous flare and cells. He had no afferent pupillary defect and no red color desaturation. He had fluorescein dye leakage from the optic disc (fig. [2a](#F2){ref-type="fig"}). There was no evidence of retinal vasculitis. Optical coherence tomography (OCT) demonstrated optic nerve head swelling and thickening (fig. [3a](#F3){ref-type="fig"}). Visual acuity was normal in the right eye with negative findings by 90-diopter slit-lamp exam, visual acuity, OCT, and fluorescein angiography. Detailed medical history was positive for a cough productive of clear sputum of recent duration, nonsmoking status, no exposure to cats, no ingestion of raw meat, and no extramarital relations. Tuberculosis was suspected. Physical exam and infectious workup were essentially negative (HIV, VDRL, *Borrelia burgdorferi*, *Brucella*, angiotensin-converting enzyme) including chest radiograph and chest CT. Purified protein derivative (PPD) skin test was strongly positive. Ten days after the initial consult, BCVA deteriorated further to 20/200 (6/60) in the left eye with increased disc swelling. He was started on treatment for presumed optic disc tuberculoma consisting of 2 months of rifampin, isoniazid, pyrazinamide, and ethambutol (respective doses: 150, 75, 400, and 275 mg) followed by 4 months of rifampin and isoniazid. One week after initiation of quadruple antituberculous therapy, vision improved to 20/30 (6/9) with decreased disc swelling. BCVA in the left eye was 20/20 (6/6) 2 weeks after initiation of therapy with a marked decrease in both disc elevation (fig. [1b](#F1){ref-type="fig"}) and fluorescein leakage (fig. [2b](#F2){ref-type="fig"}). Three months after initiation of therapy, funduscopy and OCT (fig. [3b](#F3){ref-type="fig"}) returned to normal. At follow-up 4 months after initiation of therapy, visual fields were unchanged. At the last follow-up 10 months after initiation of therapy, clinical examination was unchanged.

Discussion {#sec1_2}
==========

Optic nerve tuberculomas are rarely reported \[[@B1], [@B2], [@B3], [@B4], [@B5], [@B6]\], and their natural history, prognosis, and duration of required treatment remain unclear. Davis et al. \[[@B1]\] gathered a large series of optic disc tuberculosis in order to delineate the progress of the disease and propose the most authoritative therapeutic regimen.

In this analysis of 62 eyes from 49 patients with tuberculous optic neuropathy, papillitis was present in 51.6%, neuroretinitis in 14.5%, and optic nerve tubercle in 11.3%, with uveitis absent in 11.3% and extraocular tuberculosis absent in 63.3% of patients \[[@B1]\]. In our case, antituberculosis therapy was initiated, based on clinical evidence. The ocular findings improved remarkably with the antituberculosis treatment. An index of suspicion is required to diagnose ocular tuberculosis when all other systemic investigations are negative, especially in this part of the world where tuberculosis is endemic.

Isolated optic disc tuberculosis \[[@B1], [@B2], [@B3], [@B4], [@B5], [@B6]\], similar to isolated choroidal \[[@B7]\] or ciliary body \[[@B8]\] tuberculosis, can be the presenting form of tuberculosis in immunocompetent subjects without extraocular clinical signs or symptoms. Tuberculosis should be considered in the diagnosis of papillitis, even in asymptomatic patients. Positive PPD skin test and rapid response to antimycobacterial therapy confirm the clinical diagnosis of presumed ocular tuberculosis \[[@B9]\].
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![**a** Fundus photograph. Posterior pole of the left eye demonstrates marked swelling of the optic disc with peripapillary hemorrhage. **b** Fundus photograph. Posterior pole of the left eye 2 weeks after initiation of antimycobacterial therapy shows marked resolution of the optic disc swelling.](cop-0006-0317-g01){#F1}

![**a** Intravenous fluorescein angiography (6 min 21 s after dye injection). The left optic disc shows profuse leakage well at the venous phase transit. **b** Intravenous fluorescein angiography (8 min after dye injection). The left disc shows minimal leakage at the venous phase transit 2 weeks after initiation of therapy.](cop-0006-0317-g02){#F2}

![**a** OCT. Horizontal scan through the center of the left optic disc shows marked swelling of optic nerve head. **b** OCT. Horizontal scan through the center of the left optic disc 3 months after initiation of therapy. The left disc swelling has resolved.](cop-0006-0317-g03){#F3}
